Acquired C1 esterase-inhibitor deficiency: case report with emphasis on complement and kallikrein activation during two patterns of clinical manifestations

J Allergy Clin Immunol. 1986 Nov;78(5 Pt 1):860-7. doi: 10.1016/0091-6749(86)90231-9.

Abstract

A case of severe angioedema with several episodes of life-threatening attacks during a follow-up of 7 years is presented. Although the biologic profile is that of an acquired C1 INH deficiency, no lymphoproliferative malignancy or immune-complex disease could be proven until now. However, the patient has had a small monoclonal IgG lambda-gammopathy for 4 years. During the last 4 years, edematous manifestations have stopped. The patient now suffers at regular intervals of about a week from short-lasting attacks with digestive and vasomotor symptoms. This clinical evolution is accompanied by a worsening in the complement abnormalities. The digestive and vasomotor attacks were found to be correlated with sudden prekallikrein and high-molecular-weight kininogen consumption. These findings demonstrate that prekallikrein is activated during acquired C1 INH deficiency and that the products of this pathway such as bradykinin are probably responsible for a part of the clinical manifestations associated with this disorder.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Angioedema / physiopathology*
  • Blood Proteins / metabolism
  • Complement Activation
  • Complement C1 Inactivator Proteins / deficiency*
  • Erythema / physiopathology
  • Gastrointestinal Diseases / physiopathology
  • Humans
  • Kallikreins / physiology
  • Male
  • Periodicity

Substances

  • Blood Proteins
  • Complement C1 Inactivator Proteins
  • Kallikreins